Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Johnson PharmacareBOM:532154 14 Receivables Turnover is 0.00 as of Jun. 2026. GuruFocus rates BOM:532154 with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 68 Diversified Financial Services companies, Johnson Pharmacare ranks worse than 1470586.76% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Johnson Pharmacare's Revenue for the
three
months ended in Jun. 2026 was ₹0.00 Mil. Johnson Pharmacare's average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹22.26 Mil.
Johnson Pharmacare (BOM:532154) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Johnson Pharmacare Receivables Turnover Related Terms
Johnson Pharmacare Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Johnson Pharmacare's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532154 vs XXI, CCXI, DMII: Receivables Turnover Comparison
For the Shell Companies subindustry, Johnson Pharmacare's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Pharmacare Receivables Turnover vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Johnson Pharmacare's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Johnson Pharmacare's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Pharmacare (BOM:532154) has a Receivables Turnover of 0.00 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Johnson Pharmacare and its competitors. According to the industry distribution chart, Johnson Pharmacare ranks #999999 out of 68 companies in the Diversified Financial Services industry.
Is Johnson Pharmacare's Receivables Turnover too high?
Johnson Pharmacare's current Receivables Turnover is 0.00. Based on the distribution chart, Johnson Pharmacare ranks #999999 out of 68 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Johnson Pharmacare has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Johnson Pharmacare's Receivables Turnover compare to XXI and CCXI?
According to the Diversified Financial Services industry distribution chart, Johnson Pharmacare ranks #999999 out of 68 companies for Receivables Turnover. This places Johnson Pharmacare in the lower half of its industry. The industry median Receivables Turnover is 5.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Diversified Financial Services company?
The median Receivables Turnover among Diversified Financial Services companies is 5.43, based on 68 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Johnson Pharmacare and its competitors. For the Diversified Financial Services industry, the median Receivables Turnover is 5.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Johnson Pharmacare's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Pharmacare stock overvalued right now?
Johnson Pharmacare (BOM:532154) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Johnson Pharmacare's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Johnson Pharmacare (BOM:532154), the current Receivables Turnover is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532154 has been successfully added to your 
